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Choline is an essential nutrient for humans and is derived from
the diet as well as from de noo synthesis involving methylation
of phosphatidylethanolamine catalysed by the enzyme phos-
phatidylethanolamine N-methyltransferase (PEMT). This is the
only known pathway that produces new choline molecules. We
used mice with a disrupted Pemt-2 gene (which encodes PEMT;
Pemt−/−) that have previously been shown to possess no hepatic
PEMT enzyme. Male, female and pregnant Pemt−/− and wild-
type mice (n¯ 5–6 per diet group) were fed diets of different
choline content (deficient, control, and supplemented). Livers
were collected and analysed for choline metabolites, steatosis,
and apoptotic [terminal deoxynucleotidyl transferase-mediated
dUTP–biotin nick end-labelling (TUNEL)] positive cells. We
found that, in livers of Pemt−/− mice fed any of the diets, there
was hepatic steatosis and significantly higher occurrence of
INTRODUCTION
Choline or its derivatives are important for the structural integrity
of cell membranes, methyl metabolism, cholinergic neuro-
transmission, and transmembrane signalling as well as for
lipid–cholesterol transport and metabolism [1]. Choline was
classified as an essential nutrient for humans [2] and is a dietary
component that is crucial for normal function of all cells [1]. The
daily requirement for dietary choline is moderated by the ca-
pacity to form phosphatidylcholine (PtdCho) via the methyl-
ation of phosphatidylethanolamine using S-adenosylmethionine
(AdoMet) catalysed by phosphatidylethanolamine N-methyl-
transferase (PEMT; EC 2.1.1.17) [1]. Other important metab-
olites of choline include acetylcholine, phosphocholine (PCho),
glycerophosphocholine (GPCho), and betaine.
PtdCho is a significant component of biomembranes and is
required for the formation of the very-low-density lipoprotein
(VLDL) particle, which is responsible for delivering the triacyl-
glycerol produced by liver to other tissues [3–5]. It is believed that
most PtdCho is formed by the cytidine diphosphocholine (CDP-
choline) pathway (Scheme 1), with the alternative pathway
(PEMT) contributing approximately a third of total PtdCho
synthesis [6]. The latter is the only de noo pathway for choline
biosynthesis and the PEMT activity is most active in the liver and
Abbreviations used: AdoMet, S-adenosylmethionine ; CD, choline deficient ; Cho, choline ; GPCho, glycerophosphocholine ; PCho, phosphocholine ;
PtdCho, phosphatidylcholine ; CDP-choline, cytidine diphosphocholine ; CS, choline supplemented; CT, choline control ; LC-ESI-IDMS, liquid
chromatography–electrospray ionization–isotope dilution MS; PEMT, phosphatidylethanolamine N-methyltransferase ; TUNEL, terminal deoxynucleo-
tidyl transferase-mediated dUTP–biotin nick end-labelling; VLDL, very low density lipoprotein.
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TUNEL positive cells compared with wild-type controls. In
male, female and pregnant mice, liver phosphatidylcholine con-
centrations were significantly decreased in Pemt−/− choline de-
ficient and in Pemt−/− choline control groups but returned to
normal in Pemt−/− choline supplemented groups. Phosphocholine
concentrations in liver were significantly diminished in knockout
mice even when choline was supplemented to above dietary
requirements. These results show that PEMT normally supplies
a significant portion of the daily choline requirement in the
mouse and, when this pathway is knocked out, mice are unable
to attain normal concentrations of all choline metabolites even
with a supplemental source of dietary choline.
Key words: betaine, choline deficiency, liver steatosis,
phosphatidylcholine, phosphocholine.
kidney of mammals [6,7]. These two pathways produce different
profiles of PtdCho species : the CDP-choline pathway forms
mainly species containing medium chain, saturated fatty acids
while the PEMT pathway forms PtdCho containing significantly
more long chain polyunsaturated fatty acids [8]. These different
species of PtdCho differ in physical properties [8], and in the
signalling products they generate when hydrolysed [9].
Pemt−/− mice have two selectively disrupted alleles of the Pemt-
2 gene at exon 2 [10], which encode PEMT, and do not express
any PEMT activity in liver. Therefore these mice completely
depend on dietary choline intake to meet daily choline require-
ments. When fed a diet deficient in choline and insufficient in
methionine, Pemt−/− mice develop decreased PtdCho concen-
trations in hepatic membranes, leading to severe liver damage
and death; a choline supplemented diet prevents this [11] and, if
provided early enough, can reverse hepatic damage [12]. How-
ever, we do not know if diets containing control amounts of
choline are sufficient to meet the daily requirement for choline in
mice that are unable to form choline endogenously. This may be
especially important in pregnant animals, in which we have
previously observed a greatly increased requirement for choline
[13]. For the first time we show that, in the mouse, PEMT activity
meets a substantial portion of daily choline requirements, and
that even supplementation with four times more choline than
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Scheme 1 Pathways for PtdCho biosynthesis
There are two pathways for PtdCho biosynthesis. One via phosphorylation of choline in the CDP-
choline pathway (marked 1 on the Scheme) and the alternative via the methylation of
phosphatidylethanolamine catalysed by PEMT (marked 2 on the Scheme). Cho, choline ; PCho,
phosphocholine ; CDP-Cho, cytidine diphosphocholine ; DAG, diacylglycerol ; PtdCho, phospha-
tidylcholine ; PtdEtn, phosphatidylethanolamine ; AdoMet, S-adenosylmethionine ; Met, meth-
ionine ; Hcy, homocysteine ; Bet, Betaine ; GPCho, glycerophosphocholine.
contained in the control AIN76A diet, was not adequate to
sustain normal concentrations of all choline metabolites in liver
or normal liver function.
MATERIALS AND METHODS
Animals
Pemt−/− mice were a gift from Dr Dennis Vance, University of
Alberta, Edmonton, Canada. All animals used were housed in
cages in a climate-controlled room (24 °C) exposed to light
between 06:00–18:00 daily.
Male study
Pemt−/− and wild-type (mixed genetic background of 129}J and
C57BL}6) adult male mice (18 of each), weighing 20–25 g at the
start of the study, were fed a choline deficient diet (CD, AIN76A
diet without choline; Dyets Inc., Bethlehem, PA, U.S.A.) plus
choline in their drinking water [choline deficient (CD),
0 mM choline chloride ; control (CT), 6.4 mM choline chloride ;
choline supplemented (CS), 28.9 mM choline chloride ; n¯ 6 per
group] for 12 days. Mice ingested an average of 3 mg choline}day
in the control group, and 12 mg}day in the supplemented group.
Livers were collected after mice were anaesthetized with intra-
peritoneal 200 mg}kg Ketamine (Fort Dodge Animal Health,
Fort Dodge, KS, U.S.A.) and 16 mg}kg Xylazine (Ben Venue
Laboratories, Bedford, OH, U.S.A.).
Female study
Non-pregnant Pemt−/− and non-pregnant wild-type adult female
mice (15 of each), weighing 20–25 g at the start of study, were
given free access to water and to AIN76A diet (1.1 g choline
chloride}kg of diet) before they were randomized. Mice were
divided into treatment groups (n¯ 5 animals per group)
fed choline control (CT, AIN76A diet containing 1.1 g choline
chloride}kg diet), supplemented (CS, AIN 76A containing
4.95 g choline chloride}kg diet) or deficient (CD, AIN76A
without choline) diets. Mice ingested an average of 3 mg choline}
day in the control group, and 12 mg}day in the supplemented
group. These diets were continued for 6 days. Livers were
collected after mice were anaesthetized with intraperitoneal
200 mg}kg Ketamine (Fort Dodge Animal Health) and 16 mg}kg
Xylazine (Ben Venue Laboratories).
Pregnancy study
Timed-pregnant Pemt−/− and timed-pregnant wild-type adult
female mice, weighing 20–30 g at the start of the study, were given
free access to water and to AIN76A diet. On the evening of the
eleventh day of pregnancy, mice were divided into treatment
groups (n¯ 5 dams per group) and fed control (CT; stayed on
AIN76A diet), CS (AIN76A­4.95 g choline chloride}kg) or CD
(AIN76A without choline) diets for 6 days. Mice ingested an
average of 3 mg choline}day in the control group, and 12 mg}day
in the supplemented group. Livers were collected after mice were
anaesthetized with intraperitoneal 200 mg}kg Ketamine (Fort
Dodge Animal Health) and 16 mg}kg Xylazine (Ben Venue
Laboratories).
Choline metabolite analysis
Briefly, liver samples were frozen at ®80 °C and pulverized
under liquid nitrogen. An aliquot of 100 mg was taken from each
sample and spiked with #H-labelled internal standards of all the
analytes. For a 100 mg sample of tissue, 400 µl of methanol}
chloroform (2:1, v}v) was added, vortexed vigorously, and left
at ®20 °C overnight. Choline compounds were extracted as
described previously [14]. At the end of the extraction, tissue
samples were centrifuged at 1500 g for 5 min at 22 °C. The
supernatant was transferred to new tubes and the residues were
re-extracted with 250 µl of methanol}chloroform}water (2:1 :
0.8, by vol.). The supernatants from both extractions were
combined. To the resulting solution, 100 µl of chloroform and
then 100 µl of water were added to form two phases. After
centrifugation at 1500 g for 5 min at 22 °C, the entire aqueous
phase (which contained betaine, choline, GPCho and PCho) was
separated from the chloroform phase (which contained PtdCho).
The aqueous phase was dried by vacuum centrifugation (Speed-
Vac) and redissolved in 20 µl of water. To the aqueous solution,
800 µl of methanol was added. This resulted in precipitation of
some unwanted compounds from the solution. These insoluble
compounds, mostly proteins, were removed by centrifugation
at 1500 g for 5 min at 22 °C. A portion (10 µl) of this
final supernatant was analysed using liquid chromatography-
electrospray ionization-isotope dilution mass spectrometry (LC-
ESI-IDMS); LCQDECA quadrupole ion trap mass spectrometer
equipped with an API2 electrospray ionization source (Thermo-
Quest, San Jose, CA, U.S.A.). PtdCho in the lower organic
phase was separated from other lipids using a Bond Elut
aminopropyl column (Varian Analytical Instruments, Walnut
Creek, CA, U.S.A.) before LC-ESI-IDMS analysis. The column
was conditioned with 5 ml of hexane. Samples were constituted
in 0.5 ml of chloroform and applied to the column. After washing
the column with 4 ml of chloroform}isopropanol (2 :1, v}v) and
4 ml of 2% acetic acid in ethyl ether, PtdCho was eluted with
5 ml of methanol. This solution was further diluted based on the
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expected contents of the sample so as to fall within the linear
range of the assay, and 10 µl was analysed by LC-ESI-IDMS
[15].
Assessment of DNA fragmentation and apoptosis
DNA fragmentation was determined using a TUNEL (terminal
deoxynucleotidyl transferase-mediated dUTP–biotin nick end-
labelling) method [16] in deparaffinized 5 µm thick sections from
tissue blocks. This procedure was performed by using an in situ
cell-death detection kit according to the manufacturer’s instruc-
tions (ApoTagTM, Intergen, Purchase, NY, U.S.A.). The sections
were then counterstained with Methyl Green. Hepatic cells were
analysed in three different tissue sections per animal. Apoptotic
cells were analysed using NIH Image software version 6.1 (NIH
Research Service Branch, Bethesda, MD, U.S.A.). For each slide
three sections, each with 4.4¬10& pixels of area, were randomly
counted using a light microscope at a magnification of ¬200.
TUNEL-positive nuclei were scored under a light microscope.
The ratio of TUNEL-positive cells to the total number was
calculated.
PEMT activity measurement
PEMT was assayed using a modification of the method of
Ridgway and Vance [17]. Briefly, PEMT activity was assayed in
homogenates of mouse livers in 125 mM Tris}HCl, pH 9.2, and
5 mM dithiothreitol buffer in the presence of 200 µM [methyl-
$H] AdoMet (Perkin Elmer Life sciences, Inc., Boston, MA,
U.S.A.) and 0.4 mM exogenous phosphatidyldimethylethanol-
amine (Avanti Polar-lipids, Inc., Alabaster, AL, U.S.A.). The
reaction was carried out for 30 min at 37 °C, and was stopped
by addition of a chloroform}methanol mixture. An aliquot
of the chloroform phase was applied to a silica gel TLC plate
[Si250-PA (19C)-Silica Gel, Baker, Inc., Phillipsburg, NJ, U.S.A.]
and was developed in chloroform}methanol}acetic acid}water
(50:30:5:2, by volume). [$H]PtdCho was determined in bands
that co-migrated with authentic standards using liquid scin-
tillation spectrophotometry.
Histology study
Liver samples were obtained, fixed in 4% neutral buffered
formaldehyde (Polysciences, Warrington, PA, U.S.A.), paraffin
embedded, cut into 5 µm sections, and stained with Methyl
Green. Morphology and steatosis were evaluated using light
microscopy.
Analysis of triacylglycerol in the liver
Livers were homogenized with a motorized glass–Teflon homo-
genizer in 10 vol. of PBS. Lipids were extracted from the
homogenates in chloroform}methanol [14]. The concentration of
triacylglycerol was measured using a diagnostic kit (Sigma) that
was a modification of the enzymic colorimetric method of
McGowan et al. [18].
Statistics
To assess the effects of mouse type (knockout and wildtype) and
diet (CD, CT, and CS) on each of the study outcomes of interest,
an ANOVA for a 2¬3 cross-factorial study design was used [19].
The ANOVA model included effects due to mouse type, diet, and
interactions. Similarly, to assess the effects of pregnancy status
(pregnant and non-pregnant), mouse type and diet on each of the
study outcomes of interest, an ANOVA for a 2¬2¬3 cross-
factorial study design was used [19]. The ANOVA model included
effects due to pregnancy status, mouse type, diet, and interactions.
In most of the ANOVA models, there were significant inter-
actions. For each outcome and each analysis, several pairwise
comparisons of interest were conducted and a Bonferroni cor-
rection for multiple comparisons [19a] was used to adjust the
significance level (α¯ 0.05). Due to the large number of com-
parisons for the entire experiment, the Bonferroni correction
consisted of adjusting the significance by the number of com-
parisons for each outcome. For example, three diet comparisons
were made for male betaine levels and the Bonferroni correction
was α}3E 0.017. On the other hand, six pairwise comparisons
were made for pregnant versus non-pregnant betaine levels and
the Bonferroni correction was α}6E 0.008.
RESULTS
Hepatic PEMT activity in Pemt−/− and wild-type mice
We investigated whether there is residual PEMT activity in the
livers of Pemt−/− mice, and whether the remaining activity was
influenced by dietary choline intake. After a 12 day dietary treat-
ment, all the animals, including the Pemt−/− mice fed on CD diet,
survived. The body weights of Pemt−/− mice on CD and CT diets
decreased by an average of 20% and 10%, respectively, com-
pared with their starting baseline; all other groups gained weight
(data not shown). We observed no PEMT activity in Pemt−/−
mice on any of the diets (Table 1). PEMT activity was detected
in livers of wild-type mice and was not influenced by choline in
the diet.
Steatosis, DNA fragmentation and apoptosis in Pemt−/− mice
Onhistological examination, liver sections prepared from Pemt−/−
female mice, treated as described above, had significant steatosis
in all livers (Figure 1), while in wild-type female mice, CD, CT
and CS groups did not develop histologically detectable hepatic
steatosis in the time frame during which we fed the diets
(Figure 1). In livers from male, female and pregnant Pemt−/−
mice on all diets, and in livers of wild-type pregnant mice fed a
CD diet, triacylglycerol concentrations were increased. This did
not occur in other groups of wild-type mice on any diet (Figure
2).
On histological examination, we observed significant numbers
of TUNEL positive hepatocytes with apoptotic morphology in
all Pemt−/− livers from female mice (Figure 1). These were rarely
Table 1 Significant PEMT activity was not detected in livers of Pemt−/−
mice
Pemt−/− and wildtype adult male mice, weighing 20–25 g at the start of study, were fed choline
deficient (CD) diet (AIN76A diet without choline) plus choline in their drinking water
(choline deficient (CD), 0 mM choline chloride ; control (CT), 6.4 mM choline chloride ; choline
supplemented (CS), 28.9 mM choline chloride ; n ¯ 6 per group) for 12 days. Mice ingested an
average of 3 mg choline/day in the control group, and 12 mg/day in the supplemented group.
All animals were killed at the termination of experiment and liver tissues were collected. PEMT
activity was assayed using a radio-enzymic method as described in the Materials and methods
section. Data are expressed as means³S.E.M., n ¯ 3.
Diet





* P ! 0.017 (Bonferroni correction, 0.05/3) versus wildtype on the same diet.
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Figure 1 Pemt−/− mice develop hepatic steatosis and hepatocyte apoptosis
Non-pregnant female Pemt−/− mice and non-pregnant female wild-type mice, weighing 20–25 g
at the start of study, were given free access to water and to AIN76A diet (1.1 g choline
chloride/kg of diet) before they were randomized. Mice were divided into treatment groups
(n ¯ 5 animals per group) fed choline control (CT ; AIN76A diet containing 1.1 g choline
chloride/kg diet), supplemented (CS ; AIN 76A containing 4.95 g choline chloride/kg diet) or
deficient (CD ; AIN76A without choline) diets. Mice ingested an average of 3 mg choline/day
in the control group, and 12 mg/day in the supplemented group. These diets were continued
for 6 days. All animals were killed at the termination of experiment, liver tissues were collected
and sections were prepared from the livers for TUNEL with Methyl Green counterstaining as
described in the Materials and methods section. Apoptosis was confirmed using morphological
criteria. Representative liver sections are presented from each group at 200¬ magnification.
Apoptotic cells stain brown and are indicated by arrows in the Figure.
observed in the wild-type mouse livers on any diet. The number
of cells that were TUNEL positive in livers from Pemt−/− female
mice on CD, CT and CS diets were 6.0³0.9%, 2.8³0.2%, and
1.6³0.3%, respectively, displaying a dose–response effect. In
contrast, the number of cells that were TUNEL positive in livers
from wild-type mice on CD, CT and CS diets were 0.1³0.1%,
0³0%, and 0³0%, respectively (data are expressed as mean-
s³S.E.M. of five animals per group); all values for Pemt−/− mice
were significantly different (P! 0.017 Bonferroni correction;
0.05}3) from wild-type on same diet.
Choline and metabolite concentrations in liver were depleted in
Pemt−/− mice
In male and female mice, hepatic choline concentrations were
greatly reduced in Pemt−/− mice compared with wild-type mice
on CD or CT diets (Table 2). Choline concentrations were
similar in both groups on the CS diet. In pregnant mice, both
Pemt−/− and wild-type mice had diminished hepatic choline
concentrations on the CD and CT diets.
Betaine concentrations in livers of male mice were unaffected
by PEMT status or by diet (Table 2). In female mice, betaine
concentrations in liver increased with increasing choline in the
diet, and were significantly lower in Pemt−/− mice than in wild-
Figure 2 Triacylglycerol concentrations were increased in livers of Pemt−/−
mice compared with wild-type mice
Male and female mice were treated as described in Table legend 1 and Figure legend 2.
Pemt−/− and wild-type timed-pregnant mice, weighing 20–30 g at the start of study, were given
free access to water and to AIN76A diet (1.1 g choline chloride/kg of diet). On the evening of
pregnancy day 11, mice were divided into treatment groups (n ¯ 5 dams per group) and fed :
control (CT ; stayed on standard AIN76A diet), CS (AIN76A with 4.95 g choline chloride/kg) or
CD (AIN76A without choline) diets for 6 days. Mice ingested an average of 3 mg choline/day in
the control group, and 12 mg/day in the supplemented group. Liver tissues were homogenized
and lipids were extracted in chloroform and methanol. Triacylglycerol concentrations were
assayed using an enzymic colorimetric method as described in the Materials and methods
section. Open bars indicate Pemt−/− mice and solid bars indicate wild-type mice. Data are
expressed as the means³S.E.M. of 5–6 animals per group. *P ! 0.017 (Bonferroni
correction, 0.05/3) versus wild-type on same diet ; †P ! 0.008 (Bonferroni correction, 0.05/6)
pregnant versus non-pregnant females from the same mouse type and on the same diet.
type mice on all diets (Table 2). In pregnant dams we observed
a similar pattern, except that both Pemt−/− and wild-type mice
had diminished betaine concentrations in liver when fed the CD
diet (Table 2).
PCho concentrations in liver increased with increasing choline
in the diet, and were significantly lower in Pemt−/− mice than in
wild-type male and female mice (Table 2). In pregnant dams,
PCho concentrations were depleted in both Pemt−/− and wild-
type mouse liver on the CD and CT diets (Table 2). On the CS
diet, wild-type mice had much higher liver PCho than did
knockout mice (Table 2).
GPCho concentrations in livers of male mice were not changed
by diet or by Pemt gene status (Table 2). In females GPCho was
significantly lower on the CD diet in Pemt−/− mice. In pregnant
dams, GPCho concentrations were significantly lower in most
groups compared with non-pregnant females on the same diet
(Table 2).
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Table 2 Concentration of choline and its metabolites in livers of wildtype and Pemt−/− mice fed choline deficient (CD), control (CT) or supplemented (CS)
diets
Mice were treated, and liver tissue processed as described in the Table 1 and Figures 2 and 3 legends. Choline, betaine, phosphocholine (PCho), glycerophosphocholine (GPCho) and
phosphatidylcholine (PtdCho) concentrations were assayed using LC-ESI-IDMS as described in the Materials and methods section. Data are expressed as the means³S.E.M. of 5–6 animals per
group.
Mouse group Assay Diet …
nmoles/g of wild-type liver nmoles/g of Pemt−/− liver
CD CT CS CD CT CS
Male Choline 188³28 219³11 220³29 52³2.3* 56³4.2* 251³54
Betaine 225³19 293³26 363³60 317³42 273³58 428³140
PCho 160³20 637³183 937³159 42³12 42³4.4* 70³12*
GPCho 287³22 309³20 219³10 270³23 353³29 337³27
PtdCho 17449³1016 17786³1327 18731³804 8741³252* 10178³450* 17833³506
Female Choline 105³15 110³9.3 116³17 24³1.7* 45³9.2* 104³14
Betaine 436³76 526³63 705³109 115³16* 176³21* 426³43*
PCho 314³45 517³45 830³22 120³2.4 168³11* 255³32*
GPCho 581³45 653³77 669³141 293³19* 454³75 685³48
PtdCho 16729³398 17208³230 16896³275 8652³433* 11947³552* 16126³429
Pregnant Choline 14³1.9† 18³1.6† 72³3.9 20³7.3 14³3.4 87³33
Betaine 298³53 489³68 851³34 214³25 208³39* 417³45*
PCho 137³17 184³11 1256³428 106³11 115³5.7 287³80*
GPCho 248³38† 388³82† 371³11† 138³12 221³28 788³381
PtdCho 12609³303† 15752³241 16419³283 5439³142*† 9490³467*† 15262³594
*P ! 0.017 (Bonferroni correction : 0.05/3) versus wildtype on same diet ; †P ! 0.008 (Bonferroni correction : 0.05/6) pregnant versus female from same mouse type and on same
diet.
PtdCho concentrations in liver were not influenced by diet in
wild-type mice (males, females and pregnant; Table 2). In Pemt−/−
mice (males, females and pregnant) on the CD or CT diets,
PtdCho concentrations in livers were significantly diminished
compared with that measured in wild-type mouse livers (Table
2). In pregnant dams PtdCho concentrations were significantly
lower in CT and CD groups compared with non-pregnant
females on the same diet (Table 2).
DISCUSSION
Taken together, our studies demonstrate that Pemt−/− mice are
unable to maintain concentrations of important choline com-
pounds in liver, and develop liver dysfunction despite consuming
adequate, or, for some metabolites, supplemented amounts of
choline in the diet. This is unexpected, as the PEMT pathway for
PtdCho biosynthesis had previously been considered to be a
minor source of PtdCho [6]. Though it was previously reported
that hepatic steatosis in Pemt−/− mice can be reversed to a great
extent by treatment with choline [12], we find that dietary intake
of choline at the amounts recommended for rodents did not
reverse steatosis in livers of these mice, and though supplemental
choline diminished hepatic triacylglycerol concentrations, it did
not restore values to normal in Pemt−/− mice.
This is the first time that choline metabolism and steatosis
have been characterized in male, female and pregnant Pemt−/−
mice (Table 2). PEMT activity is increased by oestrogen [20],
thus it is harder to induce choline deficiency in females than in
males [1]. Though female rats are resistant to choline deficiency,
pregnant rats are as vulnerable to deficiency as are males [13].
During pregnancy, large amounts of choline are delivered to the
fetus across the placenta and this depletes maternal stores of
choline.As expected, inwild-type mice theCD diet was associated
with diminished concentrations of several choline compounds in
liver. In Pemt−/− mice, females were no longer resistant to choline
deficiency, and pregnant mice were extra-sensitive to a CD diet
(as assessed by PtdCho concentrations in liver). Choline concen-
trations (Table 2) and PtdCho concentrations (Table 2) in Pemt−/−
mice were depleted on CD and CT diets, but were rehabilitated
by the CS diet. It is interesting that PCho concentrations were
diminished in Pemt−/− mouse liver and were not repleted by the
CS diet. We suggest that that there was a more rapid conversion
of PCho into PtdCho via cytidylyltransferase activity. This is
consistent with previous reports that choline deficiency causes
translocation of CTP:phosphocholine cytidylyltransferase from
cytosol to endoplasmic reticulum in rat liver [21], and that
cytidylyltransferase activity is increased in Pemt−/− mice [10].
PCho is the most labile of the choline compounds in the liver [22]
and it is a novel second messenger that acts as a mitogen in 3T3
cells [23]. In females (both non-pregnant and pregnant), Pemt−/−
mice had diminished betaine concentrations on all diets.
Diminished availability of betaine should result in increased
dependence on methyltetrahydrofolate as a source of methyl
groups for the conversion of homocysteine into methionine
[24,25].
We report that increased DNA fragmentation and morpho-
logic changes characteristic of apoptosis were observed in livers
of Pemt−/− mice even when adequate or excess amounts of
choline were provided in their diets. This has previously been
described in choline deficient rat liver [26] and the apoptotic path-
way involves both a p53-dependent, NFk-B dependent pathway
[27] as well as a p53-independent apoptotic pathway [28–30].
Steatosis in choline deficiency and in the absence of PEMT
occurs, in part, because VLDL cannot be exported from liver in
the absence of the synthesis of PtdCho [3], and dietary choline
deficiency causes steatosis in mice, rats, baboons and humans
[1,3–5,31]. In addition, PEMT activity is important for secretion
of apolipoprotein B100-containing VLDL via a yet-to-be defined
mechanism that is independent of PtdCho concentration in
hepatocytes [32]. In previous reports, adding choline to the diet
of Pemt−/− mice reversed hepatic steatosis [12]. We found that
steatosis was not resolved by feeding a diet adequate in choline,
and was only partially resolved by feeding a CS diet. In addition,
Walkey and colleagues [11] found that Pemt−/− mice died on a
# 2003 Biochemical Society
992 X. Zhu and others
CD diet after 3 days, while in our study animals survived for at
least 12 d. Perhaps this apparent disagreement is due to differ-
ences in experimental methods. We studied male, female and
pregnant female mice, they studied male mice. The period that
the mice were exposed to treatment was different ; we fed
experimental diets for a longer period (6 or 12 days compared
with 3 or 4 days). We fed our mice the night before they were
killed; Waite et al. fasted their mice overnight [12]. The diets that
the mice were fed in the two experiments were different. In
our study, AIN76A purified diet was used and in the Waite et al.
study ICN (Cosa Mesa, CA, U.S.A.) purified diet was used. Our
diets contained 8.2 g}kg diet methionine. Their diets contained
3 g}kg diet methionine. In addition, the fat sources were not the
same (50 g}kg diet corn oil in our diet, 100 g}kg safflower oil in
the Waite diet [12]). In addition, we used deficient, control
(0.11% choline chloride) and supplemented choline diets
(0.495% choline chloride) ; Waite et al. [12] used only deficient
and supplemented (0.4% choline chloride) diets in their study.
Thus, they did not determine whether the recommended amounts
of dietary choline met the needs of Pemt−/− mice. These dietary
composition differences also may account for the increased
survival time of our mice, as methionine methyl groups can spare
the use of choline as a methyl donor (Scheme 1; [33]).
In summary, PEMT activity in liver provides an important
source of choline, and reduces the amount of choline that must
be consumed in the diet to maintain normal liver function.
Pemt−/− mice appear to need more choline in their diet to
sustain normal hepatic concentrations of some important choline
compounds. Liver steatosis seen in Pemt−/− mice is reduced but
not fully resolved by supplementation of the diet with choline. In
our studies, pregnant mice were the most vulnerable to dietary
availability of choline and to deletion of PEMT activity. The
fetus derives choline from maternal blood across the placenta
[34], and fetal brain development is very sensitive to the avail-
ability of choline [35–37]. We are currently conducting studies to
determine if brain development is altered in Pemt−/− mice. The
Pemt gene is polymorphic in humans, with more than 100 single
nucleotide polymorphisms present in 40 subjects studied [38]. If
any of these mutations disturb PEMT function, these humans
are likely to have increased dietary requirements for choline.
This would be especially apparent during pregnancy. We are
currently conducting experiments to determine which single
nucleotide polymorphisms in PEMT are functionally significant.
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